Prograf® (tacrolimus) – New formulation
May 24, 2018, - The FDA approved Prograf (tacrolimus) granules for oral suspension, for the prophylaxis of organ rejection in patients receiving allogeneic liver, kidney or heart transplants, in combination with other immunosuppressants.
Download PDF
